Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Hand Hygiene and Infection Control Procedures – V 2.0

Posted on By

BA-BE Studies: SOP for Hand Hygiene and Infection Control Procedures – V 2.0

Standard Operating Procedure for Hand Hygiene and Infection Control Procedures in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/130/2025
Supersedes SOP/BA-BE/130/2022
Page No. Page 1 of 8
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To outline the procedures for hand hygiene and infection control to be followed by all clinical personnel involved in BA/BE studies to minimize risk of cross-contamination, maintain aseptic conditions, and protect both subjects and staff.

2. Scope

This SOP applies to all healthcare providers, laboratory staff, nursing personnel, volunteers, and ancillary staff present in clinical units, sampling rooms, dosing areas, and biological sample handling zones within BA/BE study environments.

3. Responsibilities

  • Clinical Investigator: Ensures overall adherence to hygiene protocols and infection prevention.
  • Nursing Staff: Comply with hand hygiene during dosing, sampling, and subject handling activities.
  • Housekeeping Staff: Maintain daily disinfection routines and proper waste segregation.
  • Quality Assurance (QA): Conducts periodic audits of hand hygiene compliance and documents observations.
See also  BA-BE Studies: SOP for Verification of Study Drug Dispensing by Pharmacist - V 2.0

4. Accountability

The Facility-in-Charge or Clinical Operations Manager is accountable for ensuring the implementation of hand hygiene policies, availability of sanitation infrastructure, and staff training.

5. Procedure

5.1 Hand Hygiene Protocol

  1. All staff must perform hand hygiene:
    • Before and after direct contact with study subjects
    • Before performing any aseptic procedure (e.g., blood collection)
    • After exposure to bodily fluids or contaminated surfaces
    • Before donning and after removing gloves
  2. Acceptable methods:
    • Handwashing with antimicrobial soap and water (minimum 20 seconds)
    • Use of 70% alcohol-based hand rubs (ABHR) when hands are not visibly soiled
  3. Use designated hand hygiene stations at entry/exit points of clinical and sampling areas.

5.2 PPE and Gowning Requirements

  1. Clinical staff must wear:
    • Clean lab coats or scrub suits
    • Disposable gloves (changed between each subject)
    • Face masks when performing close-contact procedures
  2. Use Annexure-1: PPE Gowning Checklist before entering sampling or dosing areas.

5.3 Environmental Disinfection

  1. High-touch surfaces (e.g., bedrails, dosing chairs, doorknobs) to be disinfected:
    • Twice daily and after each sampling session
  2. Use freshly prepared 1% sodium hypochlorite or hospital-grade disinfectants.
  3. Document cleaning using Annexure-2: Disinfection Record Log.
See also  BA-BE Studies: SOP for Trial Registration with EudraCT - V 2.0

5.4 Infection Control in Sampling and Dosing

  1. Use sterile, single-use supplies (needles, vacutainers, alcohol swabs).
  2. Label samples in a clean zone, separate from blood collection sites.
  3. Dispose sharps immediately in puncture-proof containers.

5.5 Volunteer Education and Monitoring

  1. Educate volunteers during screening and admission about:
    • Hand hygiene stations
    • Respiratory etiquette
    • Reporting of symptoms or illness
  2. Provide access to hand rubs and tissues near volunteer beds and common areas.

5.6 Compliance Monitoring and Training

  1. Train all staff annually on hand hygiene and infection control procedures.
  2. Use Annexure-3: Staff Training Attendance Log for documentation.
  3. QA to conduct monthly hand hygiene audits using Annexure-4: Compliance Observation Checklist.

6. Abbreviations

  • BA: Bioavailability
  • BE: Bioequivalence
  • PPE: Personal Protective Equipment
  • QA: Quality Assurance
  • ABHR: Alcohol-Based Hand Rub

7. Documents

  1. PPE Gowning Checklist – Annexure-1
  2. Disinfection Record Log – Annexure-2
  3. Staff Training Attendance Log – Annexure-3
  4. Compliance Observation Checklist – Annexure-4
See also  BA-BE Studies: SOP for Training of Study Staff on Protocol and GCP - V 2.0

8. References

  • WHO Guidelines on Hand Hygiene in Healthcare
  • CDC Infection Control Guidelines
  • ICH E6(R2) – Good Clinical Practice

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: PPE Gowning Checklist

Date Staff Name Gown Mask Gloves Compliant
16/04/2025 Sunita Reddy Yes Yes Yes Yes

Annexure-2: Disinfection Record Log

Date Area Disinfectant Used Time Done By
16/04/2025 Dosing Room 1% NaOCl 08:00 AM Ajay Verma

Annexure-3: Staff Training Attendance Log

Name Department Date Trained Trainer Signature
Meena Joshi Clinical 14/04/2025 QA Officer Signed

Annexure-4: Compliance Observation Checklist

Observer Date Area Observed Hand Hygiene Compliance (%) Remarks
QA Team 15/04/2025 Sample Collection 95% 2 missed entries

Revision History:

Revision Date Revision No. Details Reason Approved By
05/01/2022 1.0 Initial Release GCP Compliance QA Head
17/04/2025 2.0 Expanded sections on PPE and audit procedures Post-pandemic SOP upgrade QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Aerosol: SOP for Validating Propellant Supply Systems – V 2.0
Next Post: Analytical Method Development: Development of Assay Methods using Classical Techniques – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version